Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data
2023 · Liver International · 110 citations
https://doi.org/10.1111/liv.15641
M
Matteo Landriscina
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
271
Papers
6.7K
Citations
46
h-index
119
i10-index
Matteo Landriscina is an academic researcher from University of Foggia. The author has contributed to research in topics: Heat shock proteins research & Cancer, Hypoxia, and Metabolism & Colorectal Cancer Treatments and Studies. The author has an h-index of 46, co-authored 231 publications.
ORCID: 0000-0003-0591-9799Papers by this author
worksNotch Signaling Modulates Hypoxia-Induced Neuroendocrine Differentiation of Human Prostate Cancer Cells
2011 · Molecular Cancer Research · 87 citations
https://doi.org/10.1158/1541-7786.mcr-11-0296
TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial–mesenchymal transition
2016 · Cell Death and Disease · 57 citations
https://doi.org/10.1038/cddis.2016.400
Lymphocyte antigen 6G6D-mediated modulation through p38α MAPK and DNA methylation in colorectal cancer
2022 · Cancer Cell International · 41 citations
https://doi.org/10.1186/s12935-022-02672-1
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells
2017 · Cancer Cell International · 36 citations
https://doi.org/10.1186/s12935-017-0457-z
Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era
2022 · Biomedicines · 36 citations
https://doi.org/10.3390/biomedicines10081927
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat